Boundless Bio, Inc. Common Stock
BOLD •
Buy Open
Signal type
Buy
Status
Open
Open Price
$1.23
Stop Loss
$0.69
Performance
26.83%
Days Open
2
Signal Setup
Signal Type Buy
Status Open
Open Date Apr 13, 2026
Open Price $1.23
Stop Loss $0.69
Timespan Day
Company Profile
Name Boundless Bio, Inc. Common Stock
Ticker BOLD
Market Cap $23.73M
Sector PHARMACEUTICAL PREPARATIONS
Latest Close $1.56
List Date Mar 28, 2024
Description
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.
Website Open Company Website